Registration
REGISTER FOR THE CONFERENCE
Apply to Exhibit
APPLICATION FOR EXHIBITION
Sponsorship
SPONSORSHIP APPLICATION
Ikata Nuclear Power Station's miscellaneous solid waste incineration facility returns to normal operation
Shikoku Electric Power Co. reported on August 20 that the miscellaneous solid waste incineration facility at Ikata Nuclear Power Station returned to normal operation at 12:15 p.m. that day after inspections and component replacements. Previously, a small amount of ash leakage had occurred beneath the ceramic filter of the facility. According to the report, at approximately 10:25 a.m. on August 13, operating personnel from a partner company discovered ash-like material beneath the ceramic filter of the operating incineration facility in the miscellaneous solid waste incinerator building of Ikata Nuclear Power Station. On-site investigation confirmed that the fallen material was ash, and the leakage had stopped. The leaked ash remained within the building and was fully recovered, amounting to 0.3 grams with a radioactivity of 8...
2026-08-20
Mellifluous Fusion and Advaiya Solutions Partner to Deliver AI and Business Technology Solutions for the Fusion Energy Industry
2026-08-20
IsoEnergy and DISA Complete Transaction to Launch U.S. Uranium Recovery and Production Company DISA Uranium
2026-08-20
Aomori Prefecture in Japan to Apply as Candidate Site for Nuclear Fusion Power Generation Demonstration Facility
2026-08-20
Wisconsin Electric Power Company signs 20-year power purchase agreement with NextEra for Point Beach nuclear plant
2026-08-20
West Engineering Delivers 30 Relay Protection and Automation Cabinets for Unit 2 of Akkuyu NPP
2026-08-20
Energy Fuels' Utah Plant's Terbium Oxide Certified by Japanese Rare Earth Permanent Magnet Manufacturer
2026-08-20
OECD Nuclear Energy Agency and the United States to Co-Host "New Nuclear Roadmap 2026" Conference
2026-08-20
South Korea plans to build an innovative self-developed fusion reactor by 2035
2026-08-20
Following the institutional partnership established between CEPID CancerThera and the Uruguayan Center for Molecular Imaging (CUDIM) in February this year, a Brazilian delegation visited Montevideo, Uruguay, from July 27 to 29 to advance the transformation of the memorandum of understanding into a concrete work plan. The visit focused on multicenter clinical trials, preclinical research, theranostics in oncology, and educational cooperation. During the visit, Brazilian researchers held working meetings with the CUDIM team, covering multiple aspects of oncology research development. CUDIM was represented by its General Director Alarico Rodriguez, as well as radiopharmacist and Technical Director of Radiopharmacy, Dr. Eduardo Osvaldo Savio Queve...
2026-08-20
Akiram Therapeutics, a Swedish clinical-stage biotechnology company, and ITM Isotope Technologies Munich SE, a German radiopharmaceutical biotechnology company, recently announced the signing of a supply agreement. Under the agreement, ITM will supply no-carrier-added lutetium-177 (nca Lu-177) to Akiram to support the clinical development of its targeted antibody-radionuclide conjugate, 177Lu-AKIR001 (AKIR001). AKIR001 is Akiram's lead radiopharmaceutical candidate, currently being investigated in clinical studies for the treatment of CD44v6-expressing solid tumors. The candidate combines the therapeutic radioisotope nca Lu-177 with a proprietary antibody targeting CD44v6. CD...
2026-08-20
Recently, the automatic radiation environment monitoring station located within the Nuclear Medical Health Industrial Park of the China (Mianyang) Science and Technology City was officially put into trial operation. As the first automatic radiation environment monitoring station in Sichuan Province to fully achieve domestic localization of core equipment and systems, it will provide radiation environment safety assurance for the development of the nuclear medical industry in the park through 24-hour uninterrupted automatic monitoring capabilities. At the automatic radiation environment monitoring station, operational data from equipment such as environmental γ dose rate monitors are updated in real time on monitoring screens. Compared with the previous approach that relied on manual on-site sampling and batch laboratory analysis, the automatic station enables continuous monitoring, reducing the time required to produce monitoring results from several days to the same day, thereby improving...
2026-08-20
Full-Life Technologies (hereinafter referred to as "Full-Life"), a privately held, fully integrated, clinical-stage international radiopharmaceutical therapy company, announced on August 20 that its radiopharmaceutical production facility in Gembloux, Belgium, has completed construction and received authorization to commence accelerator commissioning and enter the initial ramp-up phase. (Full-Life Technologies Belgium Radiopharmaceutical Production Facility) This milestone marks a significant step forward in Full-Life's vertically integrated radioisotope production capabilities moving toward formal operational status. With the completion of facility construction, the company has entered the next phase of operational preparation, including accelerator installation, phased commissioning, and validation of critical safety and operational systems.
2026-08-20
The U.S. Department of Energy's Lawrence Berkeley National Laboratory and Ideon Technologies have received funding from the DOE's Advanced Research Projects Agency-Energy (ARPA-E) to jointly develop a field-deployable active-source muon imaging technology through the Reliable Ore Characterization Using Cornerstone Sensing Technologies (ROCKS) program. The three-year project aims to enhance the detection and characterization of underground critical mineral resources. Image credit: Lawrence Berkeley National Laboratory. Muons are subatomic particles with strong penetrating capability. Previously, Ideon Technologies has used passive muons produced by cosmic rays in the atmosphere for ore body imaging in the mining sector, mapping mineral deposits and analyzing subsurface structures. However, passive muons primarily arrive from above, limiting detection angles; additionally, the natural flux is low—approximately one per square centimeter per minute—and imaging often requires days, weeks, or even months.
2026-08-20
Jeonbuk National University announced on the 20th that a research team led by Professor Bae Hak-yeol from the Department of Electronic Engineering at its College of Engineering, in collaboration with Professor Kim Tae-wan's team at Seoul National University and Q-Beam Solution, a startup affiliated with the Korea Atomic Energy Research Institute, conducted a joint study analyzing the causes of performance degradation in next-generation ferroelectric memory and neuromorphic semiconductor devices under neutron irradiation. The findings have been published in the latest issue of ACS Applied Electronic Materials. Ferroelectric semiconductors, which can maintain their polarization state even after power is disconnected, are considered a key candidate for next-generation non-volatile memory and neuromorphic computing devices. Neuromorphic computing aims to simultaneously implement both memory and computation within a single device...
2026-08-20
The second medical linear accelerator for cancer radiotherapy at Buchholz Hospital in the North Heath region of Germany has been commissioned. The device was activated by the hospital's radiotherapy department under the direction of Chief Physician Dr. Günter Bohlen, marking a further enhancement of local oncological radiotherapy capabilities. The management of Buchholz Hospital and Winsen Hospital, Dr. Franziska von Brunnig (third from right) and Dr. Martin Meyer (first from right), together with Chief Physician Dr. Günter Bohlen (second from right) and the radiotherapy team, posed for a photo at the official commissioning ceremony of the second linear accelerator at Buchholz Hospital. Photo: Buchholz-Winsen Hospital. According to available information, Buchholz Hospital...
2026-08-20
